Skip to main content

Peer Review reports

From: Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib

Original Submission
9 Jun 2023 Submitted Original manuscript
17 Jul 2023 Reviewed Reviewer Report
20 Jul 2023 Reviewed Reviewer Report
6 Aug 2023 Author responded Author comments - Kensuke Kanaoka
Resubmission - Version 2
6 Aug 2023 Submitted Manuscript version 2
13 Aug 2023 Author responded Author comments - Kensuke Kanaoka
Resubmission - Version 3
13 Aug 2023 Submitted Manuscript version 3
31 Aug 2023 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
1 Sep 2023 Editorially accepted
6 Sep 2023 Article published 10.1186/s12885-023-11360-w

You can find further information about peer review here.

Back to article page